JoseEduardoSan MartinMD

PubMed

• 1 citations
  Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.
  Pablo Guisado-Vasco, L. González-Cortijo, G. D'Errico, A. Serrera-Alvarez, G. Sotres-Fernandez, M. García-Coca, J.M. Fernández-Sousa, X.E. Luepke-Estefan, Jose A. Lope...> ;Annals of Oncology. 2021 Jul 7
• 6 citations
  Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
  Jose F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucia Fernandez de Orueta, Miguel Torralba, Jesús Fortún, Rob...> ;Medrxiv. 2021 May 25
• 5 citations
  Tumor–Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread
  Elena Prieto-García, C. Vanesa Díaz-García, Alba Agudo-López, Virginia Pardo-Marqués, Inés García-Consuegra, Sara Asensio-Peña, Marina Alonso-Riaño, Carlos Lage Gómez,...> ;Biomedicines. 2021 Mar 31
• 81 citations
  Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.
  Javier Martin-Broto, Nadia Hindi, Giovanni Grignani, Javier Martinez-Trufero, Andrés Redondo, Claudia Valverde, Silvia Stacchiotti, Antonio Lopez-Pousa, Lorenzo D'Ambr...> ;Journal for Immunotherapy of Cancer. 2020 Nov 1
• 1079 citations
  Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multico...
  , , , , , , , , , , , , , , , , , , , > ;The Lancet. Oncology. 2020 Oct 1
• 199 citations
  Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.
  Hyun Cheol Chung, Sarina Anne Piha-Paul, Jose A. Lopez-Martin, Jan H.M. Schellens, Steven Kao, Wilson H. Miller, Jean Pierre Delord, Bo Gao, David Planchard, Maya Gott...> ;Journal of Thoracic Oncology. 2020 Apr 1
• 44 citations
  Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
  Cecilia Carpio, Reda Bouabdallah, Loic Ysebaert, Juan-Manuel Sancho, Gilles Salles, Raul Cordoba, Antonio Pinto, Mecide Gharibo, Drew W. Rasco, Carlos Panizo, Jose A. ...> ;Blood. 2020 Mar 26
• 13 citations
  Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
  M. Teresa Agulló-Ortuño, Inmaculada García-Ruiz, C. Vanesa Díaz-García, Ana Belén Enguita, Virginia Pardo-Marqués, Elena Prieto-García, Santiago Ponce, Lara Iglesias, ...> ;Cancer Chemotherapy and Pharmacology. 2020 Mar 1
• 12 citations
  SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
  Margarita Majem, Elena García-Martínez, M Martinez, Eva Muñoz-Couselo, Delvys Rodriguez-Abreu, Ruth Alvarez, Ana Arance, Alfonso Berrocal, L. de la Cruz-Merino, Jose A...> ;Clinical & Translational Oncology. 2020 Jan 28
• 1385 citations
  Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
  Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. ...> ;Journal of Clinical Oncology. 2020 Jan 1
• 154 citations
  Nivolumab alone and with ipilimumab in previously treated metastatic urothelial carcinoma: CheckMate 032 nivolumab 1 mg/kg plus ipilimumab 3 mg/kg expansion cohort res...
  Padmanee Sharma, Arlene O. Siefker-Radtke, Filippo de Braud, Umberto Basso, Emiliano Calvo, Petri Bono, Michael A. Morse, Paolo A. Ascierto, Jose A. Lopez-Martin, Pete...> ;Journal of Clinical Oncology. 2019 Jul 1
• 1 citations
  Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer
  Pere Puig, Nadina Erill, Marta Terricabras, Isaac Subirana, Judit González-García, Adrià Asensi-Puig, Michael J. Donovan, Lourdes Mengual, M. Teresa Agulló-Ortuño, Mir...> ;BMC Research Notes. 2019 Jan 30
• 44 citations
  Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.
  Fernando Rivera, Manuel Benavides, Javier Gallego, Carmen Guillén-Ponce, Jose A. Lopez-Martin, Marc Küng> ;Pancreatology. 2019 Jan 1
• 15 citations
  Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors
  Daniel D. Von Hoff, Drew W. Rasco, Elisabeth I. Heath, Pamela N. Munster, Jan H.M. Schellens, Nicolas Isambert, Christophe Le Tourneau, Bert H. O'Neil, Ron H.J. Mathij...> ;Clinical Cancer Research. 2018 Sep 1
• 56 citations
  Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.
  Mónica P. Cala, María Teresa Agulló-Ortuño, Elena Prieto-García, Carolina Gonzalez-Riano, Lucía Parrilla-Rubio, Coral Barbas, Carmen Vanesa Díaz-García, Antonia García...> ;Journal of Cachexia, Sarcopenia and Muscle. 2018 Feb 20
• 6 citations
  Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study.
  Juan Martin-Liberal, Antonio Lopez-Pousa, Javier Martinez-Trufero, Javier Martin-Broto, Ricardo Cubedo, Javier Lavernia, Andrés Redondo, Jose A. Lopez-Martin, Nuria Mu...> ;Targeted Oncology. 2018 Feb 1
• 65 citations
  Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials
  Alberto Carretero-González, David Lora, Ismael Ghanem, Jon Zugazagoitia, Daniel Castellano, Juan Manuel Sepúlveda, Jose A. Lopez-Martin, Luis Paz-Ares, Guillermo Velasco> ;Oncotarget. 2018 Jan 20
• 43 citations
  Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-po...
  Andreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, Ulrik Lassen, Javier Cortes, Véronique Diéras, Marcus May, Christoph Schindler, Frederik Marmé, Juan Miguel ...> ;Investigational New Drugs. 2018 Jan 19
• 22 citations
  Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS).
  Andrés Redondo, Silvia Bagué, Daniel Bernabeu, Eduardo J. Ortiz-Cruz, Claudia Valverde, Rosa Alvarez, Javier Martinez-Trufero, Jose A. Lopez-Martin, Raquel Correa, Jos...> ;Cancer Chemotherapy and Pharmacology. 2017 Oct 16
• 4 citations
  A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
  A J Wagner, H Kindler, H Gelderblom, P Schöffski, S Bauer, P Hohenberger, H-G Kopp, J A Lopez-Martin, M Peeters, P Reichardt, A Qin, J Nippgen, R L Ilaria, P Rutkowski> ;Annals of Oncology. 2017 Mar 1
• 7 citations
  Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
  Alba Agudo-López, Elena Prieto-García, José Alemán, C. Vanesa Díaz-García, Lucía Parrilla-Rubio, Silvia Cabrera, Carmen Navarro-Ranninger, Hernán Cortés-Funes, Jose A....> ;Molecular Cancer. 2017 Feb 23
• 36 citations
  A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
  Berta Laquente, Jose A. Lopez-Martin, Donald A. Richards, Gerald Illerhaus, David Z. Chang, George P. Kim, Philip J. Stella, Dirk J. Richel, Cezary Szcylik, Stefano Ca...> ;BMC Cancer. 2017 Feb 15
• 53 citations
  Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Span...
  Javier Martin-Broto, Antonio López Pousa, Ramon De Las Penas, Xavier Garcia del Muro, Antonio Gutierrez, Javier Martinez-Trufero, Josefina Cruz, Rosa Alvarez, Ricardo ...> ;Journal of Clinical Oncology. 2016 Sep 27
• 3 citations
  Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer
  Analia Rodríguez Garzotto, C. Vanesa Díaz-García, Alba Agudo-López, Elena García, Santiago Ponce, Jose A. Lopez-Martin, Luis Paz-Ares, Lara Iglesias, M. Teresa Agulló-...> ;Medical Oncology. 2016 Aug 27
• 876 citations
  Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
  Scott J. Antonia, Jose A. Lopez-Martin, Johanna C. Bendell, Patrick A. Ott, Matthew H. Taylor, Joseph Paul Eder, Dirk Jäger, M. Catherine Pietanza, Dung T. Le, Filippo...> ;The Lancet. Oncology. 2016 Jul 1
• Join now to see all